Automated patient-tailored screening of the liver for diffuse steatosis and iron overload using MRI

American Journal of Roentgenology

Volumn 201, Issue 3, 2013, Pages 583-588

  Bashir, Mustafa R ^a   Zhong, Xiaodong ^b   Dale, Brian M ^c   Gupta, Rajan T ^a   Boll, Daniel T ^a   Merkle, Elmar M ^a,d  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b SIEMENS CORPORATE RESEARCH   (United States)

^c Siemens Healthcare   (United States)

^d UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Automated screening; Fatty liver; Hepatic steatosis; Screening

Indexed keywords

GADOXETIC ACID;

ADULT; ALGORITHM; ARTICLE; AUTOMATION; CLINICAL EFFECTIVENESS; CLINICAL PROTOCOL; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FATTY LIVER; FEMALE; HUMAN; IRON OVERLOAD; MAJOR CLINICAL STUDY; MALE; MEDICAL EXPERT; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; TIME; VALIDATION STUDY;

ALGORITHMS; FATTY LIVER; FEMALE; HUMANS; IMAGING, THREE-DIMENSIONAL; IRON OVERLOAD; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PATTERN RECOGNITION, AUTOMATED; PROSPECTIVE STUDIES; REFERENCE STANDARDS; RETROSPECTIVE STUDIES;

EID: 84884630231     PISSN: 0361803X     EISSN: 15463141     Source Type: Journal    
DOI: 10.2214/AJR.12.10051     Document Type: Article

References (30)

1. Hamilton G, Middleton MS, Bydder M, et al. Effect of PRESS and STEAM sequences on magnetic resonance spectroscopic liver fat quantification. J Magn Reson Imaging 2009; 30:145-152
2. Meisamy S, Hines CD, Hamilton G, et al. Quantification of hepatic steatosis with T1-independent, T2*-corrected MR imaging with spectral modeling of fat: blinded comparison with MR spectroscopy. Radiology 2011; 258:767-775
3. Yokoo T, Shiehmorteza M, Hamilton G, et al. Estimation of hepatic proton-density fat fraction by using MR imaging at 3.0 T. Radiology 2011; 258: 749-759
4. Yu H, Shimakawa A, McKenzie CA, Brodsky E, Brittain JH, Reeder SB. Multiecho water-fat separation and simultaneous R2 estimation with multifrequency fat spectrum modeling. Magn Reson Med 2008; 60:1122-1134
5. Ratziu V, Charlotte F, Heurtier A, et al. Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology 2005; 128:1898-1906
6. Rockey DC, Caldwell SH, Goodman ZD, Nelson RC, Smith AD. Liver biopsy. Hepatology 2009; 49:1017-1044
7. Szczepaniak LS, Babcock EE, Schick F, et al. Measurement of intracellular triglyceride stores by H spectroscopy: validation in vivo. Am J Physiol 1999; 276:E977-E989
8. Thampanitchawong P, Piratvisuth T. Liver biopsy: complications and risk factors. World J Gastroenterol 1999; 5:301-304
9. Bashir MR, Merkle EM, Smith AD, Boll DT. Hepatic MR imaging for in vivo differentiation of steatosis, iron deposition and combined storage disorder: single-ratio in/opposed phase analysis vs. dual-ratio Dixon discrimination. Eur J Radiol 2011; 81:e101-e109
10. Boll DT, Marin D, Redmon GM, Zink SI, Merkle EM. Pilot study assessing differentiation of steatosis hepatis, hepatic iron overload, and combined disease using two-point Dixon MRI at 3 T: in vitro and in vivo results of a 2D decomposition technique. AJR 2010; 194:964-971
11. Bashir MR, Dale BM, Merkle EM, Boll DT. Automated liver sampling using a gradient dual-echo Dixon-based technique. Magn Reson Med 2012; 67:1469-1477
12. Hankins JS, McCarville MB, Loeffler RB, et al. R2 magnetic resonance imaging of the liver in patients with iron overload. Blood 2009; 113:4853-4855
13. St Pierre TG, Clark PR, Chua-anusorn W, et al. Noninvasive measurement and imaging of liver iron concentrations using proton magnetic resonance. Blood 2005; 105:855-861
14. Clark JM, Diehl AM. Defining nonalcoholic fatty liver disease: implications for epidemiologic studies. Gastroenterology 2003; 124:248-250
15. Ioannou GN. Development and validation of a model predicting graft survival after liver transplantation. Liver Transpl 2006; 12:1594-1606
16. Reeder SB, Cruite I, Hamilton G, Sirlin CB. Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy. J Magn Reson Imaging 2011; 34:729-749
17. Adams LA, Lymp JF, St Sauver J, et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology 2005; 129:113-121
18. Adams LA, Waters OR, Knuiman MW, Elliott RR, Olynyk JK. NAFLD as a risk factor for the development of diabetes and the metabolic syndrome: an eleven-year follow-up study. Am J Gastroenterol 2009; 104:861-867
19. Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 1999; 116:1413-1419
20. Rubinstein E, Lavine JE, Schwimmer JB. Hepatic, cardiovascular, and endocrine outcomes of the histological subphenotypes of nonalcoholic fatty liver disease. Semin Liver Dis 2008; 28:380-385
21. Dunn W, Xu R, Wingard DL, et al. Suspected nonalcoholic fatty liver disease and mortality risk in a population-based cohort study. Am J Gastroenterol 2008; 103:2263-2271
22. Bonkovsky HL, Banner BF, Rothman AL. Iron and chronic viral hepatitis. Hepatology 1997; 25: 759-768
23. Westphalen AC, Qayyum A, Yeh BM, et al. Liver fat: effect of hepatic iron deposition on evaluation with opposed-phase MR imaging. Radiology 2007; 242:450-455
24. Bydder M, Shiehmorteza M, Yokoo T, et al. Assessment of liver fat quantification in the presence of iron. Magn Reson Imaging 2010; 28:767-776
25. Miller RA, Sampson NR, Flynn JM. The prevalence of defensive orthopaedic imaging: a prospective practice audit in Pennsylvania. J Bone Joint Surg Am 2012; 94:e18
26. Ciacci J, Taussig J, Kouri B, Bettmann M. A single institution's 1-year experience with uterine fibroid embolization marketing. J Vasc Interv Radiol 2011; 22:1236.e1-1239.e1
27. Sort P, Alvarez MA, Bargallo A, et al. Cost of screening for hepatocarcinoma in patients with cirrhosis: a prospective study (in Spanish). Gastroenterol Hepatol 2011; 34:519-523
28. Hendee WR, Becker GJ, Borgstede JP, et al. Addressing overutilization in medical imaging. Radiology 2010; 257:240-245
29. Bernstein J, Lexa FJ. Just ask: a proposal to hone the indications for sophisticated radiology examinations. J Med Pract Manage 2010; 25:360-363
30. Dinan MA, Curtis LH, Hammill BG, et al. Changes in the use and costs of diagnostic imaging among Medicare beneficiaries with cancer, 1999-2006. JAMA 2010; 303:1625-1631